Trial intelligence / Profile preview

Goal-directed vs empirical tranexamic acid administration in cardiovascular surgery

KCT0008419Phase 4Not yet recruiting

Sponsor
Korea Health Industry Development Institute
Start
May 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tranexamic acid in perioperative bleeding, sponsored by Korea Health Industry Development Institute. Planned start May 2023; status: not yet recruiting.

02

Drugs

tranexamic acid
03

Conditions

perioperative bleeding

Beyond the preview

Go deeper on KCT0008419.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0008419.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call